Maintenance outage: This site will be inaccessible from late evening Mar 7th thru Mar 8th. This is for scheduled technology upgrades by our global hosting service that are affecting numerous websites and online journals. Note that our submission site is still accessible during this period and processing of new submissions will not be affected.
Follow this preprint
The Paxlovid Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences Between Paxlovid and Untreated COVID-19 Participants
View ORCID ProfileJay A. Pandit, View ORCID ProfileJennifer M. Radin, View ORCID ProfileDanielle Chiang, View ORCID ProfileEmily Spencer, View ORCID ProfileJeff Pawelek, Mira Diwan, Leila Roumani, View ORCID ProfileMichael Mina
doi: https://doi.org/10.1101/2022.11.14.22282195
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Jay A. Pandit
1Scripps Research Translational Institute, La Jolla, California
Jennifer M. Radin
1Scripps Research Translational Institute, La Jolla, California
Danielle Chiang
1Scripps Research Translational Institute, La Jolla, California
Emily Spencer
1Scripps Research Translational Institute, La Jolla, California
Jeff Pawelek
1Scripps Research Translational Institute, La Jolla, California
Mira Diwan
1Scripps Research Translational Institute, La Jolla, California
Leila Roumani
2eMed, Miami, Florida
Michael Mina
2eMed, Miami, Florida

Posted November 15, 2022.
The Paxlovid Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences Between Paxlovid and Untreated COVID-19 Participants
Jay A. Pandit, Jennifer M. Radin, Danielle Chiang, Emily Spencer, Jeff Pawelek, Mira Diwan, Leila Roumani, Michael Mina
medRxiv 2022.11.14.22282195; doi: https://doi.org/10.1101/2022.11.14.22282195
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
2
Community Reviews
0
Automated Services
31
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3112)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13049)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4871)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3072)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (963)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4639)
- Nursing (247)
- Nutrition (689)
- Oncology (2395)
- Ophthalmology (678)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (307)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7205)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)